This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Aug 26;466(7310):1054-5.

doi: 10.1038/4661054a.

Cancer: Viruses' backup plan

PMID: 20740004
DOI: 10.1038/4661054a

Comment

Cancer: Viruses' backup plan

Kevin M Ryan. Nature. 2010.

. 2010 Aug 26;466(7310):1054-5.

doi: 10.1038/4661054a.

Author

PMID: 20740004
DOI: 10.1038/4661054a

No abstract available

PubMed Disclaimer

Comment on

Heterochromatin silencing of p53 target genes by a small viral protein.
Soria C, Estermann FE, Espantman KC, O'Shea CC. Soria C, et al. Nature. 2010 Aug 26;466(7310):1076-81. doi: 10.1038/nature09307. Nature. 2010. PMID: 20740008 Free PMC article.

Similar articles

Enhanced oncolytic potency of replicative adenovirus expressing p53.
Nemunaitis J, Cunningham C, Senzer N. Nemunaitis J, et al. Drug Resist Updat. 2003 Feb;6(1):5-7. doi: 10.1016/s1368-7646(02)00142-5. Drug Resist Updat. 2003. PMID: 12654282 No abstract available.
Heterochromatin silencing of p53 target genes by a small viral protein.
Soria C, Estermann FE, Espantman KC, O'Shea CC. Soria C, et al. Nature. 2010 Aug 26;466(7310):1076-81. doi: 10.1038/nature09307. Nature. 2010. PMID: 20740008 Free PMC article.
Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency.
van Beusechem VW, van den Doel PB, Grill J, Pinedo HM, Gerritsen WR. van Beusechem VW, et al. Cancer Res. 2002 Nov 1;62(21):6165-71. Cancer Res. 2002. PMID: 12414643
Cancer therapy based on p53.
McCormick F. McCormick F. Cancer J Sci Am. 1999 May-Jun;5(3):139-44. Cancer J Sci Am. 1999. PMID: 10367167 Review. No abstract available.
Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?
Dix BR, Edwards SJ, Braithwaite AW. Dix BR, et al. J Virol. 2001 Jun;75(12):5443-7. doi: 10.1128/JVI.75.12.5443-5447.2001. J Virol. 2001. PMID: 11356950 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Detection of extracellular RNAs in cancer and viral infection via tethered cationic lipoplex nanoparticles containing molecular beacons.
Wu Y, Kwak KJ, Agarwal K, Marras A, Wang C, Mao Y, Huang X, Ma J, Yu B, Lee R, Vachani A, Marcucci G, Byrd JC, Muthusamy N, Otterson G, Huang K, Castro CE, Paulaitis M, Nana-Sinkam SP, Lee LJ. Wu Y, et al. Anal Chem. 2013 Dec 3;85(23):11265-74. doi: 10.1021/ac401983w. Epub 2013 Nov 13. Anal Chem. 2013. PMID: 24102152 Free PMC article.
Rotavirus-encoded nonstructural protein 1 modulates cellular apoptotic machinery by targeting tumor suppressor protein p53.
Bhowmick R, Halder UC, Chattopadhyay S, Nayak MK, Chawla-Sarkar M. Bhowmick R, et al. J Virol. 2013 Jun;87(12):6840-50. doi: 10.1128/JVI.00734-13. Epub 2013 Apr 10. J Virol. 2013. PMID: 23576507 Free PMC article.

References

1. Cancer Cell. 2002 Aug;2(2):103-12 - PubMed
1. Oncogene. 2005 Nov 21;24(52):7673-85 - PubMed
1. Nature. 2010 Aug 26;466(7310):1076-81 - PubMed
1. Virology. 2009 Feb 20;384(2):256-9 - PubMed
1. Cancer Cell. 2004 Dec;6(6):611-23 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database